Ownership history in MARSHALL WACE, LLP · 10 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in CENTURY THERAPEU (IPSC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 54,161 | -85,546 | -61.2% | 0.00% | $27K | $0.50 |
| 2025 Q2 | ADDED | 139,707 | +104,196 | +293.4% | 0.00% | $78K | $0.56 |
| 2024 Q4 | REDUCED | 35,511 | -74,805 | -67.8% | 0.00% | $36K | $1.01 |
| 2023 Q1 | ADDED | 110,316 | +52,818 | +91.9% | 0.00% | $383K | $3.47 |
| 2022 Q4 | REDUCED | 57,498 | -643,840 | -91.8% | 0.00% | $295K | $5.13 |
| 2022 Q3 | UNCHANGED | 701,338 | — | 0% | 0.02% | $6.9M | $9.89 |
| 2022 Q2 | UNCHANGED | 701,338 | — | 0% | 0.01% | $5.9M | $8.40 |
| 2022 Q1 | UNCHANGED | 701,338 | — | 0% | 0.02% | $8.8M | $12.59 |
| 2021 Q4 | ADDED | 701,338 | +589,786 | +528.7% | 0.02% | $11.1M | $15.86 |
| 2021 Q3 | INITIATED | 111,552 | — | — | 0.01% | $2.8M | $25.16 |
As of 2025 Q4 — sorted by position size